Exploring P2X receptor activity: A journey from cellular impact to electrophysiological profiling

被引:2
作者
Dunker, Calvin [1 ,5 ]
Vinnenberg, Laura [2 ]
Isaak, Andreas [1 ]
Karabatak, Elif [3 ]
Hundehege, Petra [2 ]
Budde, Thomas [3 ]
Murakami, Kazuhiro [4 ]
Junker, Anna [1 ,5 ]
机构
[1] Univ Munster, EIMI, Roentgenstr 16, D-48149 Munster, Germany
[2] Univ Hosp Muenster, Dept Neurol, Inst Translat Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[3] Univ Munster, Inst Physiol 1, Robert Koch Str 27a, D-48149 Munster, Germany
[4] Kanazawa Univ, Canc Res Inst, Div Epithelial Stem Cell Biol, Kanazawa, Ishikawa 9201192, Japan
[5] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Roentgenweg 13, D-72076 Tubingen, Germany
基金
日本学术振兴会;
关键词
P2X receptors; HEK-293; Whole-cell patch-clamp; CD4+T-cells; ION CHANNELS; INTERNATIONAL UNION; STRUCTURAL MOTIF; ATP-BINDING; IDENTIFICATION; MICROGLIA; RELEASE; RAT; PHARMACOLOGY; ACTIVATION;
D O I
10.1016/j.bcp.2024.116543
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of in vitro pharmacological assays relies on creating genetically modified cell lines that overexpress the target protein of interest. However, the choice of the host cell line can significantly impact the experimental outcomes. This study explores the functional characterization of P2X7 and P2X4 receptor modulators through cellular assays and advanced electrophysiological techniques. The influence of different host cell lines (HEK-293, HEK-293FT, and 1321N1) on the activity of reference agonists and antagonists targeting human and murine P2X4 and P2X7 receptors was systematically investigated, highlighting the significant impact of the host cell on experimental results. The 1321N1 cell line was identified as the preferred host cell line when investigating the human P2X4 receptor due to more consistent agonist activities, antagonist potencies, and a more stable assay signal window. Furthermore, a patch-clamp protocol that allows for the repetitive recording of ATP-mediated inward currents from isolated human CD4+ T-cells was established, revealing that both P2X7 and P2X4 receptors are crucial for immune cell regulation, positioning them as promising therapeutic targets for managing inflammatory disorders.
引用
收藏
页数:13
相关论文
共 72 条
[1]   International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Boeynaems, Jean-Marie ;
Barnard, Eric A. ;
Boyer, Jose L. ;
Kennedy, Charles ;
Knight, Gillian E. ;
Fumagalli, Marta ;
Gachet, Christian ;
Jacobson, Kenneth A. ;
Weisman, Gary A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :281-341
[2]   Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies [J].
Abdelrahman, Aliaa ;
Namasivayam, Vigneshwaran ;
Hinz, Sonja ;
Schiedel, Anke C. ;
Koese, Meryem ;
Burton, Maggi ;
El-Tayeb, Ali ;
Gillard, Michel ;
Bajorath, Juergen ;
de Ryck, Marc ;
Mueller, Christa E. .
BIOCHEMICAL PHARMACOLOGY, 2017, 125 :41-54
[3]   Expression of P2X7 Receptor Increases In Vivo Tumor Growth [J].
Adinolfi, Elena ;
Raffaghello, Lizzia ;
Giuliani, Anna Lisa ;
Cavazzini, Luigi ;
Capece, Marina ;
Chiozzi, Paola ;
Bianchi, Giovanna ;
Kroemer, Guido ;
Pistoia, Vito ;
Di Virgilio, Francesco .
CANCER RESEARCH, 2012, 72 (12) :2957-2969
[4]   Identification and Characterization of a Selective Allosteric Antagonist of Human P2X4 Receptor Channels [J].
Ase, Ariel R. ;
Honson, Nicolette S. ;
Zaghdane, Helmi ;
Pfeifer, Tom A. ;
Seguela, Philippe .
MOLECULAR PHARMACOLOGY, 2015, 87 (04) :606-616
[5]   High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP:: A role for P2X7 receptors [J].
Aswad, F ;
Kawamura, H ;
Dennert, G .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :3075-3083
[6]   Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential [J].
Baudelet, Davy ;
Lipka, Emmanuelle ;
Millet, Regis ;
Ghinet, Alina .
CURRENT MEDICINAL CHEMISTRY, 2015, 22 (06) :713-729
[7]   Pharmacological characterization of recombinant human and rat P2X receptor subtypes [J].
Bianchi, BR ;
Lynch, KJ ;
Touma, E ;
Niforatos, W ;
Burgard, EC ;
Alexander, KM ;
Park, HS ;
Yu, HX ;
Metzger, R ;
Kowaluk, E ;
Jarvis, MF ;
van Biesen, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) :127-138
[8]   P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages [J].
Bowler, JW ;
Bailey, RJ ;
North, RA ;
Surprenant, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) :567-575
[9]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[10]   Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation [J].
Brock, Valerie J. ;
Lory, Niels Christian ;
Moeckl, Franziska ;
Birus, Melina ;
Staehler, Tobias ;
Woelk, Lena-Marie ;
Jaeckstein, Michelle ;
Heeren, Joerg ;
Koch-Nolte, Friedrich ;
Rissiek, Bjoern ;
Mittruecker, Hans-Willi ;
Guse, Andreas H. ;
Werner, Rene ;
Diercks, Bjoern-Philipp .
FRONTIERS IN IMMUNOLOGY, 2024, 15